SU-E-T-87: Comparison Study of Dose Reconstruction From Cylindrical Diode Array Measurements, with TLD Measurements and Treatment Planning System Calculations in Anthropomorphic Head and Neck and Lung Phantoms

2014 ◽  
Vol 41 (6Part12) ◽  
pp. 242-242
Author(s):  
S Benhabib ◽  
R Cardan ◽  
A Faught ◽  
M Huang ◽  
I Brezovich ◽  
...  
2018 ◽  
Vol 17 (4) ◽  
pp. 441-446 ◽  
Author(s):  
Jalil ur Rehman ◽  
Muhammad Isa ◽  
Nisar Ahmad ◽  
H. M. Noor ul Huda Khan Asghar ◽  
Zaheer A. Gilani ◽  
...  

AbstractBackgroundAccurate three-dimensional dosimetry is essential in modern radiotherapy techniques such as volumetric-modulated arc therapy (VMAT) and intensity-modulated radiation therapy (IMRT). In this research work, the PRESAGE® dosimeter was used as quality assurance (QA) tool for VMAT planning for head and neck (H&N) cancer.Material and methodComputer tomography (CT) scans of an Image Radiation Oncology Core (IROC) H&N anthropomorphic phantom with both IROC standard insert and PRESAGE® insert were acquired separately. Both CT scans were imported into the Pinnacle (9.4 version) TPS for treatment planning, where the structures [planning target volume (PTV), organs at risk) and thermoluminescent detectors (TLDs) were manually contoured and used to optimise a VMAT plan. Treatment planning was done using VMAT (dual arc: 182°–178°, 178°–182°). Beam profile comparisons and gamma analysis were used to quantify agreement with film, PRESAGE® measurement and treatment planning system (TPS) calculated dose distribution.ResultsThe average ratio of TLD measured to calculated doses at the four PTV locations in the H&N phantom were between 0·95 to 0·99 for all three VMAT deliveries. Dose profiles were taken along the left–right, the anterior–posterior and superior–inferior axes, and good agreement was found between the PRESAGE® and Pinnacle profile. The mean value of gamma results for three VMAT deliveries in axial and sagittal planes were found to be 94·24 and 93·16% when compared with film and Pinnacle, respectively. The average values comparing the PRESAGE® results and dose values calculated on Pinnacle were observed to be 95·29 and 94·38% in the said planes, respectively, using a 5%/3 mm gamma criteria.ConclusionThe PRESAGE® dose measurements and calculated dose of pinnacle show reasonable agreement in both axial and sagittal planes for complex dual arc VMAT treatment plans. In general, the PRESAGE® dosimeter is found to be a feasible QA tool of VMAT plan for H&N cancer treatment.


2015 ◽  
Vol 31 (3) ◽  
pp. 219-223 ◽  
Author(s):  
Rafael García-Mollá ◽  
Noelia de Marco-Blancas ◽  
Jorge Bonaque ◽  
Laura Vidueira ◽  
Juan López-Tarjuelo ◽  
...  

Author(s):  
Luong Thi Oanh ◽  
Duong Thanh Tai ◽  
Hoang Duc Tuan ◽  
Truong Thi Hong Loan

The purpose of this study is to verify and compare the three Dimensional Conformal Radiation Therapy (3D-CRT) dose distributions calculated by the Prowess Panther treatment planning system (TPS) with Monte Carlo (MC) simulation for head-and-neck (H&N) patients. In this study, we used the EGSnrc Monte Carlo code which includes BEAMnrc and DOSXYZnrc programs. Firstly, the clinical 6 MV photon beams form Siemens Primus linear accelerator at Dong Nai General Hospital were simulated using the BEAMnrc. Secondly, the absorbed dose to patients treated by 3D-CRT was computed using the DOSXYZnrc. Finally, the simulated dose distributions were then compared with the ones calculated by the Fast Photon Effective algorithm on the TPS, using the relative dose error comparison and the gamma index using global methods implemented in PTW-VeriSoft with 3%/3 mm. There is a good agreement between the MC and TPS dose. The average gamma passing rates were 92.8% based on the 3%/3 mm. The average dose in the PTV agreed well between the TPS with 0.97% error. MC predict dose was higher than the mean dose to the parotid glands and spinal cord compared to TPS. We have implemented the EGSnrc-based Monte Carlo simulation to verify the 3D-CRT plans generated by Prowess Panther TPS. Our results showed that the TPS agreed with the one of MC.  


2021 ◽  
Vol 161 ◽  
pp. S1603-S1604
Author(s):  
L. calmels ◽  
D. Sjöström ◽  
Z. Pohl ◽  
P. Sibolt

2021 ◽  
Author(s):  
Vaitheeswaran Ranganathan

Abstract When specifying a clinical objective for a target volume and normal organs/tissues in IMRT planning, the user may not be sure if the defined clinical objective could be achieved by the optimizer. To this end, we propose a novel method to predict the achievability of clinical objectives upfront before invoking the optimization. A new metric called “Geometric Complexity (GC)” is used to estimate the achievability of clinical objectives. Essentially GC is the measure of the number of “unmodulated” beamlets or rays that intersect the Region-of-interest (ROI) and the target volume. We first compute the geometric complexity ratio (GCratio) between the GC of a ROI in a reference plan and the GC of the same ROI in a given plan. The GCratio of a ROI indicates the relative geometric complexity of the ROI as compared to the same ROI in the reference plan. Hence GCratio can be used to predict if a defined clinical objective associated with the ROI can be met by the optimizer for a given case. We have evaluated the proposed method on six Head and Neck cases using Pinnacle3 (version 9.10.0) Treatment Planning System (TPS). Out of total of 42 clinical objectives from six cases accounted in the study, 37 were in agreement with the prediction, which implies an agreement of about 88% between predicted and obtained results. The results indicate the feasibility of using the proposed method in head and neck cases for predicting the achievability of clinical objectives.


Sign in / Sign up

Export Citation Format

Share Document